开运电竞

×
  • 业务领域联系

    中国:

    Email: marketing@czchengteng.com

    金融业务在线咨询直达:400-780-8018 (只能的服务详询,任何相关事宜请呼叫川沙总店手机) 川沙直销店的电话: +86 (21) 5859-1500

    海外:

    +1(781)535-1428(U.S.) 0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

在线留言×
点击切换
Customer Center
客户中心

通过增强MTUS1稳定性抑制透明细胞肾细胞癌转移,本研究中体外实验重组蛋白通过美迪西合成和纯化

2025-06-12
|
访问量:

Clear cell renal cell carcinoma (ccRCC) is the most prevalent histological subtype of kidney cancer and is believed to mainly originate from proximal tubular epithelial cells of the nephron.

MTUS1 was significantly downregulated in ccRCC tissues, especially in metastatic tissues. Knockdown of MTUS1 decreased microtubule stability, whereas increased microtubule dynamics by promoting the ratio of unphosphorylated KIF2CS192 adapting to high motility of metastatic cancer cells.

MTUS1 is a potent microtubule-stabilizing protein19, so we assessed the impact of MTUS1 knockdown on microtubule dynamics.

MTUS1 regulates microtubule dynamics via promoting KIF2CS192 phosphorylation by Aurora B.

Western blot and immunohistochemistry further confirmed significantly lower expression of SORBS2 protein in metastatic tissues than that in primary tissues and normal tissues.

Western blot and co-immunoprecipitation (Co-IP):

Wild-type recombinant protein KIF2CWT (1 μg), pointed mutant KIF2CS192A (1 μg), Aurora B (100 ng), and MTUS1 (100 or 500 ng) (recombinant proteins were synthesized and purified by Medicilon) were incubated with 0.2 μCi/μl [γ-32P]-ATP and 30 μM non-radioactive ATP for 30 min at 37°C.

78.jpgReference:

 


对应新闻视频
×
搜索验证
点击切换